Abstract:Necroptosis is a caspase-independent modality of cell death implicated in many inflammatory pathologies. The execution of this pathway requires the formation of a cytosolic platform that comprises RIPK1 and RIPK3 which, in turn, mediates the phosphorylation of the pseudokinase MLKL (S345 in mouse). The activation of this executioner is followed by its oligomerisation and accumulation at the plasma-membrane where it leads to cell death via plasma-membrane destabilisation and consequent permeabilisation. While the biochemical and cellular characterisation of these events have been amply investigated, the study of necroptosis involvement in vivo in animal models is currently limited to the use of Mlkl −/− or Ripk3 −/− mice. Yet, even in many of the models in which the involvement of necroptosis in disease aetiology has been genetically demonstrated, the fundamental in vivo characterisation regarding the question as to which tissue(s) and specific cell type(s) therein is/are affected by the pathogenic necroptotic death are missing. Here, we describe and validate an immunohistochemistry and immunofluorescence-based method to reliably detect the phosphorylation of mouse MLKL at serine 345 (pMLKL-S345). We first validate the method using tissues derived from mice in which Caspase-8 (Casp8) or FADD are specifically deleted from keratinocytes, or intestinal epithelial cells, respectively. We next demonstrate the presence of necroptotic activation in the lungs of SARS-CoV-infected mice and in the skin and spleen of mice bearing a Sharpin inactivating mutation. Finally, we exclude necroptosis occurrence in the intestines of mice subjected to TNF-induced septic shock. Importantly, by directly comparing the staining of pMLKL-345 with that of cleaved Caspase-3 staining in some of these models, we identify spatio-temporal and functional differences between necroptosis and apoptosis supporting a role of RIPK3 in inflammation independently of MLKL versus the role of RIPK3 in activation of necroptosis.

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Structural Insights into RIP3-Mediated Necroptotic Signaling

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo

Biological events and molecular signaling following MLKL activation during necroptosis

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis

Regulation of Ripk3-And Rhim-Dependent Necroptosis by the Proteasome

Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity.